FDA approves arimoclomol as first drug to treat Neimann-Pick disease, type C
The approval is indicated for adults and children aged 2 years and older, making arimoclomol (Miplyffa) the first drug approved by the FDA to treat NPC.
Food Insecurity and the Dangers of Infant Formula Dilution
Comparing safety of JAK inhibitors between adolescent, adult patient
In this analysis, the differences in adverse events resulting from JAKi among adults and children were evaluated.
Demystifying Infant Formula
Low-food access in early life associated with higher subsequent child BMI, obesity risk
Investigators found the association for higher BMI, increased obesity risk, and increased severe obesity risk.
Study: Disturbed sleep at 10 years of age associated with suicidal thoughts 2 years later
Preadolescent sleep disturbances were linked to an increased risk of suicidal thoughts and behaviors in early adolescence, highlighting sleep as a key intervention target.
